Контакты/Проезд  Доставка и Оплата Помощь/Возврат
История
  +7(495) 980-12-10
  пн-пт: 10-18 сб,вс: 11-18
  shop@logobook.ru
   
    Поиск книг                    Поиск по списку ISBN Расширенный поиск    
Найти
  Зарубежные издательства Российские издательства  
Авторы | Каталог книг | Издательства | Новинки | Учебная литература | Акции | Хиты | |
 

Antiangiogenic Agents in Cancer Therapy, Teicher Beverly A., Ellis Lee M.


Варианты приобретения
Цена: 27950.00р.
Кол-во:
Наличие: Поставка под заказ.  Есть в наличии на складе поставщика.
Склад Америка: Есть  
При оформлении заказа до: 2025-07-28
Ориентировочная дата поставки: Август-начало Сентября
При условии наличия книги у поставщика.

Добавить в корзину
в Мои желания

Автор: Teicher Beverly A., Ellis Lee M.
Название:  Antiangiogenic Agents in Cancer Therapy
ISBN: 9781493956289
Издательство: Springer
Классификация:

ISBN-10: 1493956280
Обложка/Формат: Paperback
Страницы: 559
Вес: 0.95 кг.
Дата издания: 23.08.2016
Серия: Cancer drug discovery and development
Язык: English
Издание: Softcover reprint of
Иллюстрации: 34 tables, black and white; xviii, 559 p.; 34 tables, black and white; xviii, 559 p.
Размер: 24.41 x 16.99 x 3.12 cm
Читательская аудитория: General (us: trade)
Ссылка на Издательство: Link
Рейтинг:
Поставляется из: Германии
Описание: Antiangiogenesis remains a dynamic and evolving field in oncology. New therapeutic targets continue to emerge followed by the rapid development of new therapeutic agents to be investigated in clinical trials. Optimizing the therapeutic potential of antiangiogenic agents in combination with the other therapies in the armamentarium to fight cancer will be an on-going challenge. Antiangiogenic Agents in Cancer Therapy, Second Edition provides a current, up-dated perspective on the state of the art of angiogenesis and therapy with a compendium of scientific findings and approaches to the study of angiogenesis in cancer. Leaders in the field present chapters on such topics as the environmental influences and the genetic and physiologic abnormalities that mediate angiogenesis and its role in the progression of malignant disease, working models of tumor angiogenesis, and the role of angiogenesis inhibition in the therapy of malignant disease in humans. Comprehensive and cutting-edge, Antiangiogenic Agents in Cancer Therapy, Second Edition is an ideal, valuable guide to the most recent advances in the field, and a collection that will be useful for many years to come.
Дополнительное описание: Basic Biology of Angiogenesis.- Vascular Endothelial Growth Factor Family and Its Receptors.- The Cycle Between Angiogenesis, Perfusion, and Hypoxia in Tumors.- The Role of Integrins in Tumor Angiogenesis.- Tumor Endothelial Cell Abnormalities.- The Extra



Antiangiogenic Cancer Therapy

Название: Antiangiogenic Cancer Therapy
ISBN: 0367388812 ISBN-13(EAN): 9780367388812
Издательство: Taylor&Francis
Рейтинг:
Цена: 9798.00 р.
Наличие на складе: Есть у поставщика Поставка под заказ.

Описание: Top Investigators Explore the Complexities of Angiogenesis Cancer Research

The targeting of tumor angiogenesis has evolved into one of the most widely pursued therapeutic strategies. However, as of yet, no antiangiogenic agent used as a monotherapy has demonstrated a survival benefit in a randomized Phase III trial. The combination of bevacizumab, the first FDA approved angiogenesis inhibitor, with cytotoxic regimens has led to survival benefits in cancer patients. This has raised important questions about the complexities inherent in the clinical application of angiogenesis inhibitors.

Compiles the results of four decades of progress

Integrating fundamental concepts with therapeutic strategies, Anti-Angiogenic Cancer Therapy promotes the idea that an understanding of the molecular and cellular regulation of angiogenesis leads to optimal therapeutic strategies and positive clinical results. It brings together contributions from leading researchers to provide the most authoritative and encyclopedic volume available on this subject.

  • Examines the role of angiogenesis in cancer, including strategies to prolong the nonangiogenic dormant state of human tumors, molecular mechanisms and cellular regulation of angiogenesis in solid tumors and hematologic malignancies, and the regulation of angiogenesis by the tumor microenvironment.
  • Covers specific molecular targets for inhibiting angiogenesis in cancer therapy.
  • Discusses clinical trial design and translational research approaches essential for identifying and developing effective angiogenesis inhibitors.
  • Outlines current understanding of the molecular biology of each cancer type followed by discussions that examine strategies for targeting angiogenesis in specific cancers.
  • This volume celebrates progress made in four decades, and more importantly, it provi


    ООО "Логосфера " Тел:+7(495) 980-12-10 www.logobook.ru
       В Контакте     В Контакте Мед  Мобильная версия